Lexaria Bioscience Corp.

Healthcare · Biotechnology · Canada

Last price 3.49 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 7.35M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Lexaria Bioscience Corp. operates as a biotechnology company. The company offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing for improved tolerability while promoting healthier oral ingestion methods. Its DehydraTECH is used with a range of active molecules, including ...